Health9 hours ago
Cabaletta Bio Reports Positive CAR-T Trial Results for Autoimmune Disorder
Cabaletta Bio, a biotechnology company based in Philadelphia, has announced promising early results from its clinical trial of CAR-T therapy aimed at treating a rare autoimmune...